Literature DB >> 15619547

A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm.

Masahiro Asaeda1, Makoto Sakamoto, Masamichi Kurosaki, Sadaharu Tabuchi, Hideki Kamitani, Masayuki Yokota, Takashi Watanabe.   

Abstract

We performed serial measurements of 8-iso-prostaglandin F2alpha (8-iso-PGF2alpha), a non-enzymatic derived arachidonyl peroxide, in the cerebrospinal fluid (CSF) of 34 patients with subarachnoid hemorrhage (SAH). Patients were treated with open or endovascular surgery within 48 h of onset. Delayed cerebral vasospasm was verified by the presence of a low-density area on CT scan indicating focal cerebral infarction occurring after symptomatic delayed vasospasm. Concentrations of 8-iso-PGF2alpha in the CSF of 15 patients exhibiting delayed cerebral vasospasm were compared with those of 19 patients who did not exhibit vasospasm. The concentrations of 8-iso-PGF2alpha in the CSF of patients showing vasospasm were 42.4+/-37.1 pg/ml (mean+/-S.D., n=12) on Days 0-2, 66.4+/-41.0 pg/ml (n=14) on Days 3-5, 118.5+/-89.9 pg/ml (n=15) on Days 6-8, 86.2+/-70.2 pg/ml (n=11) on Days 9-11, 48.8+/-31.8 pg/ml (n=10) on Days 12-14, 27.8+/-20.1 pg/ml (n=7) after Day 20, while the concentrations in patients not showing vasospasm were 24.8+/-12.0 pg/ml (n=18) on Days 0-2, 25.7+/-15.2 pg/ml (n=19) on Days 3-5, 47.5+/-52.3 pg/ml (n=18) on Days 6-8, 56.7+/-72.0 pg/ml (n=13) on Days 9-11, 34.2+/-53.1 pg/ml (n=15) on Days 12-14, 20.1+/-18.2 pg/ml (n=10) after Day 20. CSF concentrations of 8-iso-PGF2alpha on Days 3-5 and Days 6-8 were significantly higher in patients showing vasospasm as compared to patients not showing vasospasm. CSF levels of 8-iso-PGF2alpha in patients showing vasospasm gradually increased in the days after onset of SAH and peaked on Days 6-8. Levels returned to normal after Day 20. These values on Days 3-5, Days 6-8, and Days 9-11 were significantly higher than the value after Day 20. Considering these data and the biological activities of 8-iso-PGF2alpha, such as development of inflammation, membrane perturbation and vasoconstriction, we conclude that 8-iso-PGF2alpha may play a role in delayed cerebral vasospasm after SAH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619547     DOI: 10.1016/j.neulet.2004.10.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury?

Authors:  Tomas B Corcoran; Emilie Mas; Anne E Barden; Thierry Durand; Jean-Marie Galano; L Jackson Roberts; Michael Phillips; Kwok M Ho; Trevor A Mori
Journal:  Antioxid Redox Signal       Date:  2011-07-22       Impact factor: 8.401

2.  Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles.

Authors:  Takahiro Murata; Hans H Dietrich; Tetsuyoshi Horiuchi; Kazuhiro Hongo; Ralph G Dacey
Journal:  Neurosci Res       Date:  2015-12-19       Impact factor: 3.304

3.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 4.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

5.  Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.

Authors:  Luo Fei; Filimon Golwa
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 6.  The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.

Authors:  Stefan Wanderer; Basil E Grüter; Fabio Strange; Sivani Sivanrupan; Stefano Di Santo; Hans Rudolf Widmer; Javier Fandino; Serge Marbacher; Lukas Andereggen
Journal:  Brain Sci       Date:  2020-03-07

7.  Levosimendan as a therapeutic strategy to prevent neuroinflammation after aneurysmal subarachnoid hemorrhage?

Authors:  Stefan Wanderer; Lukas Andereggen; Jan Mrosek; Sepide Kashefiolasl; Gerrit Alexander Schubert; Serge Marbacher; Jürgen Konczalla
Journal:  J Neurointerv Surg       Date:  2021-05-26       Impact factor: 5.836

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.